Summary
The effects of acute calcium entry blockade by isradipine (IS) and placebo (P) on the haemodynamic and humoral responses to angiotensin II (A II) have been compared in two groups of 9 patients with essential hypertension. During 4 sequential periods each of 20 min, an i.v. infusion of A II 0, 2, 4 and 8 ng · kg−1 · min−1 was given before (control) and 30 min after the oral administration either of IS or P.
After IS, both the blood pressure and the angiotensin II-induced pressor effect were significantly reduced. Isradipine increased the heart rate and this cardio-acceleration was potentiated by A II. In contrast, when A II was infused in the absence of IS, heart rate tended to decrease. IS stimulated plasma renin activity and reduced plasma aldosterone. However, it did not affect either the inhibition of plasma renin activity or the rise in plasma aldosterone in response to A II.
In conclusion, acute calcium entry blockade in patients with essential hypertension reduces the pressor response to A II, but not the A II-induced inhibition of renin and increase in plasma aldosterone.
Similar content being viewed by others
References
Snyder SH, Reynolds IJ (1985) Calcium-antagonist drugs. Receptor interactions that clarify therapeutic effects. N Engl J Med 313: 995–1002
Guthrie GP Jr, McAllister RG Jr, Kotchen TA (1983) Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man. J Clin Endocrinol Met 57: 339–343
Bianchetti MG, Beretta-Piccoli C, Weidmann P, Boehringer K, Link L, Morton JJ (1982) Studies on aldosterone responsiveness to angiotensin II during clinical variations in calcium metabolism in normal man. Clin Sci 63: 325–328
Millar JA, Struthers AD, Beastall GH, Reid JL (1982) Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans. J Cardiovasc Pharmacol 4: S330-S334
Vierhapper H, Waldhäusl W (1982) Reduced pressor effect of angiotensin II and of noradrenaline in normal man following the oral administration of the calcium-antagonist nifedipine. Eur J Clin Med 12: 263–267
Millar JA, McLean KA, Summer DJ, Reid JL (1983) The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man. Eur J Clin Pharmacol 24: 315–321
Marone C, Luisoli S, Bomio F, Beretta-Piccoli C, Bianchetti MG, Weidmann P (1985) Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after clacium entry blockade with nifedipine. Kidney Int 28: 658–665
Pasanisi F, Elliot HL, Reid JL (1985) Vascular and aldosterone responses to angiotensin II in normal humans: effects of nicradipine. J Cardiovasc Pharmacol 7: 1171–1175
Simon G, Snyder DK (1984) Altered pressor responses in long-term nitrendipine treatment. Clin Pharmacol Ther 36: 315–319
Hollenberg NK, Chenitz WR, Adams DF, Williams FH (1974) Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54: 34–42
Moerman EJ, De Schaepdryver AF (1984) Quantitation of catecholamines in urine and in plasma. Clin Chim Acta 139: 321–333
Fyhrquist F, Puutula L (1978) Faster radioimmunoassay of angiotensin I at 37°C. Clin Chim 24: 115–118
Lijnen PJ, Amery AK, Fagard RH, Katz FH (1978) Radioimmunoassay of angiotensin II in unextracted plasma. Clin Chim Acta 88: 403–412
Lijnen P, Amery A, Fagard R, Corvol P (1978) Direct radioimmunosassay of plasma aldosterone in normal subjects. Clin Chim Acta 84: 305–314
Orth D (1979) Adrenocorticotropic hormone. In: Jaffe BM, Behrman HR (eds) Methods of hormone radioimmunoassay, 2nd edn. Academic Press, New York, pp 245–284
Armitage P (1980) Statistical methods in medical research. Blackwell Scientific, Oxford, pp 253–259
Hof RP, Scholtysik G, Loutzenhiser R, Vuorela HJ, Neumann P (1984) PN 200-110 a new calcium antagonist: Electrophysiological, inotropic and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol 6: 399–406
Hof RP, Hof A, Scholtysik G, Menninger K (1984) Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol 6: 407–416
Casteels R (1984) Calcium-ions and excitation contraction coupling in vascular smooth muscle cells. In: Godfraind T, Herman AG, Wellens D (eds) Calcium entry blockers in cardiovascular and cerebral dysfunctions. Martinus Nijhoff, Boston, pp 45–52
Cauvin C, Lautzenhiser R, Van Breemen C (1983) Mechanisms of calcium antagonist-induced vasodilation. Ann Rev Pharmacol Toxicol 23: 373–396
Freer RJ (1975) Calcium and angiotensin tachyphylaxis in rat uterine smooth muscle. Am J Physiol 228: 1423–1430
d'Auriac GA, Baudouin M, Meyer P (1972) Mechanism of action of angiotensin in smooth muscle cell. Circ Res 31 [Suppl II]: II-151–II-160
Kojima I, Kojima K, Kreuter D, Rasmussen H (1984) The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways. J Biol Chem 259: 14448–14755
Kojima I, Kojima K, Rasmussen H (1985) Role of calcium fluxes in the sustained phase of angiotensin II-mediated aldosterone secretion from adrenal glomerulosa cells. J Biol Chem 260: 9177–9184
Anderson JM, Gimbrone MA Jr, Alexander RW (1981) Angiotensin II stimulates phosphorylation of the myosin light chain in cultured vascular smooth muscle cells. J Biol Chem 256: 4693–4696
Lederballe Pedersen O, Mikkelsen E, Christensen NJ, Kornerup HJ, Pedersen EB (1979) Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. Eur J Clin Pharmacol 15: 235–240
Kuchel D (1983) The autonomic nervous system and blood pressure regulation in human hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M (eds) Hypertension. McGraw-Hill, New York, pp 140–160
Staessen J, Lijnen P, Fagard R, Hespel P, Tan WP, Devos P, Amery A (1989) Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension. J Cardiovasc Pharmacol 13: 271–276
Churchill PC (1985) Second messengers in renin secretion. Am J Physiol 249: F175-F184
Vandongen R, Peart WS (1974) Calcium dependence of the inhibitory effect of angiotensin on renin secretion in the isolated perfused kidney of the rat. Br J Pharmacol 50: 125–129
Vandongen R (1975) Inhibition of renin secretion in the isolated rat kidney by antidiuretic hormone. Clin Sci Mol Med 49: 73–76
Park CS, Han DS, Fray JLS (1981) Calcium in the control of renin secretion: Ca2+ influx as an inhibitory signal. Am J Physiol 240: F70-F74
Naftilan AJ, Oparil S (1982) The role of calcium in the control of renin release. Hypertension 4: 670–675
Vanbreemen C, Aaronson P, Loutzenhiser R (1979) Sodiumcalcium interactions in mammalian smooth muscle. Pharmacol Rev 30: 167–208
Phillis JW, Wu PH (1981) Catecholamines and the sodium pump in excitable cells. Prog Neurobiol Oxford 17: 141–184
Rasmussen H (1986) The calcium messenger system: First of two parts. N Engl J Med 314: 1094–1101
Rasmussen H (1986) The calcium messenger system: Second of two parts. N Engl J Med 314: 1164–1170
Fakunding JL, Chow R, Catt JJ (1979) The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II- and potassium in isolated glomerulosa cells. Endocrinology 105: 327–333
Foster RM, Lobo V, Rasmussen H, Marnsie ET (1981) Calcium: Its role in the mechanism of action of angiotensin II and potassium in aldosterone production. Endocrinology 109: 2196–2201
Kojima K, Kojima I, Rasmussen H (1984) Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion. Am J Physiol 247: E645-E650
Foster R, Rasmussen H (1983) Angiotensin-mediated calcium efflux from adrenal glomerulosa cells. Am J Physiol 245: E281-E287
Fagard R, Lijnen P, Moerman E, Staessen J, Amery A (1987) Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension. Eur J Clin Pharmacol 32: 71–75
Weber MA (1987) A one-year experience with the calcium channel blocking agent nitrendipine in patients with essential hypertension. J Cardiovasc Pharmacol 10 [Suppl 1]: S161-S164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staessen, J., Fagard, R., Hespel, P. et al. Acute calcium entry blockade inhibits the blood pressure but not the hormonal responses to angiotensin II. Eur J Clin Pharmacol 36, 567–573 (1989). https://doi.org/10.1007/BF00637737
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637737